Phase 3 Lung Carcinoma Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer.
Small Cell Lung Carcinoma
AstraZeneca70 enrolled15 locationsNCT06992609
Recruiting
Phase 3
Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial
Small Cell Lung Carcinoma
Instituto de Investigación Biomédica de Salamanca300 enrolled13 locationsNCT07015892
Recruiting
Phase 3
A Study to Evaluate the Safety and Tolerability of SCTB14 as First-Line Therapy in Non-Small Cell Lung Cancer.
Non-Small Cell Lung Carcinoma (NSCLC)
Sinocelltech Ltd.246 enrolled1 locationNCT07362459
Recruiting
Phase 3
Low Dose Nivolumab With Chemotherapy vs Standard Chemotherapy as First-Line Treatment in Advanced or Metastatic NSCLC
NSCLC (Non-small Cell Lung Carcinoma)First Line TherapyLocally Advanced/Metastatic NSCLC
Dr Arvindran A/L Alaga123 enrolled1 locationNCT07050043
Recruiting
Phase 3
A Phase IIII Study of AL8326 in Small Cell Lung Cancer
Small Cell Lung Carcinoma
Advenchen Laboratories Nanjing Ltd.243 enrolled1 locationNCT06247605